CRISPR Therapeutics AG
Long

CRSP start of wave 3

101
Enough smart money may have entered the CRISPR/Cas field now.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.